QSC / "Tracy"
This is one entry from the TitrateLab Vendor Graveyard, a dated, primary-source archive of peptide-market shutdowns, exit scams, and enforcement actions. Documented as December 2024 disappearance, August 2025 "comeback", March 2026 third wave. Sources for this entry are named inline below and numbered in full on the parent archive page.
The canonical chronic-disappearance case. Worth documenting precisely because it doesn’t fit the clean exit-scam pattern, the operator went dark, reappeared, burned a second cohort of customers, and as of late March 2026 is mid-way through a third disruption that exhibits the same pattern with the same talking points.
Full investigation: Does Tracy deserve a break? — QSC priced its own reviews and charged the customers who stayed quiet. It also turns out to have the best worst-case lab record of any vendor its size, tested across ten independent laboratories, at roughly a quarter of Western retail pricing. That piece measures QSC against size- and product-matched peers, controls for who paid for each test, and reaches a split verdict. This entry remains the timeline of record; the investigation is the argument.
QSC (Qingdao Sigma Chemical) is a China-based research-peptide vendor, at various points the single most-recommended international source in GLP-1-adjacent forums. Orders were handled through a sales rep going by “Tracy”, who used the profile photo of Chinese actress Zhang Xinyu on messaging platforms and later conceded in a published interview that the avatar was “useful packaging” rather than fandom.
Timeline: - Late 2024 — QSC ran aggressive promotional pricing through late-year holidays. Orders shipped normally until approximately December 20. - December 26, 2024, first forum thread documenting non-delivery: a $130 wire for Tirzepatide 10mg kit with Tracy and Bella (another QSC contact) initially claiming they hadn’t received payment, then blaming their bank, then going silent (GLP-1 Forum thread). - January 9, 2025 — “Tracy gone MIA?” thread on GLP-1 Forum; community consensus that orders across the cohort had stalled. - February 2025 — Tracy surfaces on MESO-Rx claiming “70% of issues resolved, 30% remaining” without firm timeline. - August 1, 2025 — “Official Comeback Announcement” via Telegram, in which Tracy cited arrests, seized machinery, and confiscated stock as the cause of the seven-month gap. - November 2025, a MESO-Rx customer posts contemporaneously that they wired $7,500 for an order (thread); package was returned from the destination country on February 25, 2026, and Tracy went unresponsive on the reship/refund negotiation despite having agreed. - Mid-March 2026 — international order accumulation. QSC accepts hundreds of international orders during a sale window, then a multi-week period begins where international packages don’t ship, tracking numbers aren’t logged, customers are silent-treatment’d. Domestic operations (USA, UK, EU, AU, Canada warehouses) continue running normally throughout. - Late March / early April 2026 — Tracy publishes a single broadcast message to the customer cohort explaining the situation. Verbatim text in the next sub-section. Pattern is identical to August 2025: arrests cited, no proof offered, no refunds, no order modifications, no individual responses; customer is told to wait. - June 8, 2026 — MESO-Rx permanently bans QSC as a source. The ban notice is a signed administrator post in QSC’s own vendor thread. The stated ground is not the shipping dispute: the administrator writes that the source “publicly posted screenshots and supporting information relating to a customer who was complaining about a missing order” with redactions that were “grossly inadequate”, such that “the combination of address fragments, ZIP code information, tracking details, map imagery, neighborhood geography, and other location-specific clues allowed third parties to reconstruct and identify the customer’s exact residence within minutes”, and that the source additionally disclosed the customer’s cryptocurrency payment address. The notice concludes: “Effective immediately, the source is permanently banned … because the source engaged in severe and dangerous doxxing of a customer.” This matters beyond one forum: MESO-Rx is one of the two community sources this archive relies on for QSC, and the ban removes the venue where the December 2024 and November 2025 losses were documented. - July 27, 2026 — QSC publishes a four-message album on its Telegram channel naming a customer it accuses of spreading false seizure claims, reproducing his order history, tracking dashboard, private direct messages and forum posts. We are not reproducing any of it and do not name him. - July 28, 2026 — QSC announces to its Telegram channel, then at roughly 34,700 subscribers, that promotional pricing will from that point depend on whether the customer has posted public reviews. In QSC’s own words: “From now on, promo prices will look different depending on who you are. Call it a loyalty discount. Call it a tax for the ungrateful.” The post asks for “something public that help us grow”, specifying “Forums, reddit, TG groups, discords”. A channel post the following day claims MESO-Rx banned roughly 40 accounts in response; that figure appears in no forum artefact and rests on QSC’s assertion alone.
The March 2026 broadcast — verbatim:
I think it's time I give you some context. Believe it or not, that's up to you — but here's the situation.
You may have noticed that many international orders have been delayed, and some are missing tracking numbers. That's because the logistics hub where we keep our stock and handle shipments became part of a temporary unwanted official attention. It turns out that some other clients of theirs were involved in something serious — let's just say it's the kind of thing that draws unwanted attention. As a result, the person who manages our shipments was taken for a chat. He's expected to be done with formalities in the coming days, as he's clearly not involved, but the whole thing has brought our operations to a crawl.
Before this happened, he shipped many international orders but didn't log the tracking into the system we share. So some of you might receive your package before ever seeing a tracking number. Others may not have been shipped yet — and honestly, I won't be able to tell which is which until he's back.
For the ones we know haven't shipped, we're already arranging to move some fresh stock to another logistics partner — though we can't move everything out of the affected warehouse just yet.
That said, let's be real: you're in this space, and you know what comes with it. You take a risk, we take a bigger one. A little patience isn't too much to ask. If you're worried about missing your next dose or dealing with an unhappy customer somewhere down your own chain — honestly, that's not my priority right now.
No refunds, no order changes, no credits — not until you have a tracking number in hand. That's going to take a few more days. Every message asking for updates will go unanswered, because I can't reply to everyone individually. You already know the answer: either your order shows up without tracking, or you'll get the number when it's ready.
Domestic operations (USA, UK, EU, AU, Canada) are running normally — no delays, no issues. Don't make this harder than it already is. Shit happens in this business. Wait patiently.
Pattern recognition: the March 2026 message reuses the same template as the August 2025 comeback announcement: an unverifiable third-party-arrest narrative, a refusal to provide individual updates, an explicit “no refunds” policy, a “you took the risk” framing that shifts liability onto the customer, and a domestic-still-works carve-out that retains revenue from one cohort while the international cohort waits indefinitely. This is the third time in 16 months that QSC has used the “logistics partner / shipper / warehouse arrest” explanation, and the second time it has been deployed to a cohort whose orders had already been paid in advance.
Community characterization in the post-comeback period: individual MESO-Rx commenters have described QSC’s operator as a recurring bad actor on that forum; GLP-1 Forum commenters summarize the pattern as the operator having “disappeared, came back, made no one right.” Original customers from the December 2024 cohort report no compensation despite the comeback announcement’s promise to “make good” pending orders. New orders placed post-comeback have largely been fulfilled domestically, which community analysts read as the operator selling fresh inventory while carrying the pre-comeback obligations and now the March 2026 international cohort as unpaid liability.
Impersonator fraud layer: a separate scam ecosystem has developed around the QSC brand, in which actors not affiliated with QSC contact potential customers via WhatsApp, Telegram, Instagram, and Reddit claiming to be “Tracy.”
A GLP-1 Forum alert from August 2023 stated that QSC communicated only through official email and the qsc-usa.com website, and that any third-party messaging contact was a scammer. That rule is now out of date and following it today would produce the wrong answer. QSC’s own operator has since used Telegram as its primary broadcast channel: the August 2025 comeback announcement, the March 2026 international-cohort broadcast and the July 2026 posts quoted above were all delivered there, on the channel @qsctgchannel, and ordering moved to a Telegram bot on July 14, 2026. A buyer applying the 2023 test would classify QSC’s real channel as fraud.
The 2023 alert’s underlying point survives in weaker form: unsolicited contact from an account claiming to be “Tracy” is a well-documented scam vector, and the impersonation problem is real. But “messaging platform therefore scammer” is no longer a usable rule for this vendor, and we should not have carried it forward unqualified alongside the Telegram broadcasts this same entry reproduces as authentic. Verify the channel identity rather than the channel type.
Why it belongs in the archive: QSC is different from a clean exit scam because the brand didn’t die. It’s the most-documented case in our corpus of a vendor that went dark with customer funds, then returned to continue operations without resolving the outstanding losses. The pattern is distinct from both the charismatic-founder exit scam (WellnessBuy/Sandy) and the FDA-enforcement shutdown (Amino Asylum), and it’s currently operating, which makes the incident live in a way the other entries in this archive aren’t.
We don't recommend QSC for international orders, and we treat the March 2026 broadcast as a near-textbook restatement of the August 2025 playbook. A vendor with unresolved customer losses from two prior disruption cycles, in our view, carries elevated reputational risk until those losses are addressed in a verifiable way.
On domestic fulfilment. Domestic-warehouse orders (USA, UK, EU, AU, Canada) continued to be reported as arriving through late July 2026. That is not our inference: QSC's MESO-Rx vendor thread carried at least twenty favourable received-order reports from around eighteen distinct accounts in the thirty days to July 28, 2026, covering US, UK and EU warehouses, all of them posted before the review-pricing announcement that makes later reviews difficult to weigh. We are re-dating this line rather than withdrawing it, because the evidence for it is better than it was in April. International orders should still be considered at material risk of indefinite hold.
On the June ban and the July review pricing. These are matters of public record and we report them as such: a signed forum administrator notice, and QSC's own announcement in its own words. We take no position here on QSC's characterisation of MESO-Rx's motives, and we have not verified QSC's claim about the number of accounts banned. Reviews of QSC posted publicly after July 28, 2026 should be read in the knowledge that the vendor has tied pricing to posting them.
Our data pipeline continues to ingest Janoshik COAs tied to QSC batches because the batch-level chemistry is still useful; the trust question is separate.
Primary sources: MESO-Rx customer-loss thread; GLP-1 Forum timeline threads; QSC operator interview; QSC impersonator alert; March 2026 international-cohort thread; MESO-Rx permanent-ban notice; QSC Telegram channel archive.